Phyllis B. Malpas
1Patents
1h-index
4Co-inventors
25Inventor score
Filing activity: Jul 18, 2013 → Jul 18, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9522151B2 | Dosing regimen for Janus Kinase (JAK) inhibitors | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.